Non-invasive brain tumor testing and monitoring
Part of Brain & nervous system, Cancer clinical trials.
This study is testing a new, non-invasive way to diagnose and monitor brain tumors. It may offer a less risky option compared to traditional biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 years or older).
- You must have a brain tumor.
- You must not have any other type of cancer.
- You must not have an inflammatory disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cancer and its treatment affect thinking and memory. It may help doctors understand and predict these changes, which could improve care.
This trial tests whether customized drug screening on your tumor cells can help doctors choose the best treatment for you. Your tumor cells will be grown in the lab and tested against different drugs to find what works best, combined with short-course radiation therapy.
This study tests a new way to monitor brain activity during surgery to remove brain tumors. It may help doctors better protect important brain functions during the operation.
This study adds special brain “biomarker” tests into routine visits for adults with brain tumors. It may help the clinic better track these cancers over time and tailor care.
This trial tests a new way to take a tiny tissue sample from a suspected glioblastoma using ultrasound, to improve noninvasive detection. You may be able to get this targeted sample while you’re already planning surgery for tumor removal.
This trial studies whether a blood test can track the progress of a type of brain tumor called a grade 4 diffuse glioma. It may offer a less invasive way to monitor these tumors after surgery.
Hear when a new Brain Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.